CMS Ends Medicare Part D Premium Program Before 2027
The Centers for Medicare and Medicaid Services will end the temporary Medicare Part D Premium Stabilization Demonstration before the 2027 plan year, the agency announced July 28, 2026.
The change affects Medicare prescription-drug coverage nationwide, but it does not end Medicare Part D. It ends the temporary program that was created to limit premium increases and help control prescription-drug plan costs during a period of changes to the Medicare drug benefit.
The announcement came before Medicare Open Enrollment, when beneficiaries will prepare to compare coverage for 2027. The financial effect of ending the demonstration is expected to differ among plans and enrollees rather than produce one uniform change for everyone.
What the temporary program did
CMS introduced the Part D Premium Stabilization Demonstration in 2024. The program was created after changes under a 2022 law that altered Medicare prescription-drug costs. Its purpose was to limit premium increases and reduce the immediate cost pressure faced by some prescription-drug plans and their enrollees.
The demonstration was temporary. CMS’s decision means that the stabilization mechanism will not continue into the 2027 plan year, following two years in which the program was available.
That timing makes the decision relevant to the next coverage-comparison cycle. Beneficiaries who use Medicare Part D will review the plans available to them for 2027 without the temporary stabilization program operating in the same way.
Costs will vary by plan and beneficiary
Ending the demonstration could increase premiums or other costs for some people enrolled in Medicare prescription-drug plans. The Associated Press reported that experts expected the effect to be marginal for some beneficiaries but more substantial for others.
The difference will depend on the plan and the individual beneficiary. The decision therefore should not be read as a determination that every Medicare enrollee will pay more. It establishes the end of a federal cost-stabilization measure, while the effect on a particular person will depend on the coverage they consider for 2027.
Medicare Part D serves beneficiaries throughout the United States. The nationwide program includes prescription-drug plans whose premiums and other costs can differ, making the end of a temporary nationwide mechanism relevant to beneficiaries as they assess their available options.
Separate from Affordable Care Act subsidies
The Part D decision is separate from the expiration of enhanced Affordable Care Act subsidies for working-age enrollees. Those subsidies apply to people who obtain health coverage through Affordable Care Act marketplaces, while the CMS action concerns Medicare prescription-drug plans.
The two issues involve different federal health programs and different groups of enrollees. The end of the Part D demonstration affects the Medicare prescription-drug coverage system for the 2027 plan year; it does not change the fact that Medicare Part D remains in operation.
For Medicare beneficiaries, the next relevant step is the 2027 enrollment period. The CMS announcement establishes that the temporary stabilization program will no longer be part of the Part D system for that plan year, while the eventual effect on premiums and other costs will differ across plans and beneficiaries.
Sources
Look for updates to this story
Discover more from Interactive News
Subscribe to get the latest posts sent to your email.